Connect Biopharma is trading 14.98% up at $0.84 in pre-market; no company-specific announcement explaining the move was found. - Its investor page lists September 30 as the latest press release, reporting preliminary Phase 2 COPD data. - The Nasdaq is higher and the Dow lower, offering no clear broad-market explanation for the gain. - The next reported earnings date is November 11, not November 6.